Yuezhu Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuezhu Wang has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Caroline B. Dixon
Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina
16 shared publications - Dawen Zhao
Department of Cancer Biology, Wake Forest University School of Medicine , Winston-Salem, North Carolina
16 shared publications - Fei Xing
Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA
16 shared publications - George Oliver
Department of Pharmacy, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
16 shared publications - Jason M. Grayson
Department of Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America
16 shared publications - Jimmy Ruiz
Department of Internal Medicine, Section of Hematology and Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
16 shared publications
Latest Publications
- Open Access
- 9 July 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 222, 111686
A multimodal MRI–radiomics deep learning model for survival risk stratification after gamma knife radiosurgery in patients with brain metastases: A multicenter retrospective study
- 9 July 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 222, 111686
Open AccessA multimodal MRI–radiomics deep learning model for survival risk stratification after gamma knife radiosurgery in patients with brain metastases: A multicenter retrospective study
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1-16 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer
Supplementary Table 1-16 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1-16 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer
Supplementary Table 1-16 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer